Literature DB >> 1911187

Genetic alterations within the retinoblastoma locus in colorectal carcinomas. Relation to DNA ploidy pattern studied by flow cytometric analysis.

G I Meling1, R A Lothe, A L Børresen, S Hauge, C Graue, O P Clausen, T O Rognum.   

Abstract

Alterations within the retinoblastoma (Rb) gene, as detected by the VNTR probe p68RS2.0, and flow cytometric DNA pattern have been analysed in 255 colorectal carcinomas. A total of 35.3% of the tumours had alterations within the Rb gene. Amplification of one allele was demonstrated in 29.5% of the tumours, and loss of heterozygosity was found in 11.5%. No association was found between amplification within the Rb gene and clinicopathological characteristics of the patients. The high frequency of alterations demonstrated within the Rb gene, suggests that this gene is involved in colorectal carcinogenesis with amplification as by far the most abundant genetic alteration. This may imply that the Rb gene has an oncogene-like function in colorectal carcinomas, rather than acting as a tumour suppressor gene. Sixty-three per cent of the carcinomas were DNA aneuploid, and a significant association was demonstrated between amplification within the Rb gene and DNA aneuploidy (P less than 0.01). Two other chromosome loci were analysed, on chromosome 1p (probe pYNZ2) and on chromosome 2p (probe pYNH24), respectively. On chromosome 1p, heterozygous loss was found in 22.2% of the tumours, indicating an involvement of this chromosome in a subset of colorectal carcinomas.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1911187      PMCID: PMC1977625          DOI: 10.1038/bjc.1991.334

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  37 in total

1.  p53 functions as a cell cycle control protein in osteosarcomas.

Authors:  L Diller; J Kassel; C E Nelson; M A Gryka; G Litwak; M Gebhardt; B Bressac; M Ozturk; S J Baker; B Vogelstein
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

2.  Association between DNA ploidy pattern and cellular atypia in colorectal carcinomas. A new clinical application of DNA flow cytometric study?

Authors:  G I Meling; T O Rognum; O P Clausen; Y Chen; O C Lunde; E Schlichting; J N Wiig; J Hognestad; A Bakka; O Havig
Journal:  Cancer       Date:  1991-03-15       Impact factor: 6.860

3.  Loss of constitutional heterozygosity in colon carcinoma from patients with familial polyposis coli.

Authors:  M Okamoto; M Sasaki; K Sugio; C Sato; T Iwama; T Ikeuchi; A Tonomura; T Sasazuki; M Miyaki
Journal:  Nature       Date:  1988-01-21       Impact factor: 49.962

Review 4.  Tumor suppressor genes.

Authors:  C J Marshall
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

5.  Existence of two distinct processes of chromosomal evolution in near-diploid colorectal tumors.

Authors:  M Muleris; R J Salmon; B Dutrillaux
Journal:  Cancer Genet Cytogenet       Date:  1988-05

6.  p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis.

Authors:  S J Baker; A C Preisinger; J M Jessup; C Paraskeva; S Markowitz; J K Willson; S Hamilton; B Vogelstein
Journal:  Cancer Res       Date:  1990-12-01       Impact factor: 12.701

7.  Genetic alterations during colorectal-tumor development.

Authors:  B Vogelstein; E R Fearon; S R Hamilton; S E Kern; A C Preisinger; M Leppert; Y Nakamura; R White; A M Smits; J L Bos
Journal:  N Engl J Med       Date:  1988-09-01       Impact factor: 91.245

8.  Concerted nonsyntenic allelic loss in human colorectal carcinoma.

Authors:  D J Law; S Olschwang; J P Monpezat; D Lefrançois; D Jagelman; N J Petrelli; G Thomas; A P Feinberg
Journal:  Science       Date:  1988-08-19       Impact factor: 47.728

9.  Characterization of bladder tumours by multiparameter flow cytometry with special reference to grade II tumours.

Authors:  B Kirkhus; O P Clausen; H Fjordvang; K Helander; O H Iversen; J B Reitan; S Vaage
Journal:  APMIS       Date:  1988-09       Impact factor: 3.205

10.  Human colorectal cancer: high frequency of deletions at chromosome 1p35.

Authors:  I Leister; A Weith; S Brüderlein; C Cziepluch; D Kangwanpong; P Schlag; M Schwab
Journal:  Cancer Res       Date:  1990-11-15       Impact factor: 12.701

View more
  17 in total

1.  Expression of p53, p21/waf, bcl-2, bax, Rb and Ki67 proteins in colorectal adenocarcinomas.

Authors:  P Kanavaros; K Stefanaki; K Valassiadou; J Vlachonikolis; M Mavromanolakis; M Vlychou; S Kakolyris; V Gorgoulis; M Tzardi; V Georgoulias
Journal:  Med Oncol       Date:  1999-04       Impact factor: 3.064

2.  Genetic and epigenetic changes of components affecting the WNT pathway in colorectal carcinomas stratified by microsatellite instability.

Authors:  Lin Thorstensen; Guro E Lind; Tone Løvig; Chieu B Diep; Gunn I Meling; Torleiv O Rognum; Ragnhild A Lothe
Journal:  Neoplasia       Date:  2005-02       Impact factor: 5.715

3.  Evaluation of 1p losses in primary carcinomas, local recurrences and peripheral metastases from colorectal cancer patients.

Authors:  L Thorstensen; H Qvist; S Heim; G J Liefers; J M Nesland; K E Giercksky; R A Lothe
Journal:  Neoplasia       Date:  2000 Nov-Dec       Impact factor: 5.715

4.  Progression from colorectal adenoma to carcinoma is associated with non-random chromosomal gains as detected by comparative genomic hybridisation.

Authors:  G A Meijer; M A Hermsen; J P Baak; P J van Diest; S G Meuwissen; J A Beliën; J M Hoovers; H Joenje; P J Snijders; J M Walboomers
Journal:  J Clin Pathol       Date:  1998-12       Impact factor: 3.411

5.  RAS signaling in colorectal carcinomas through alteration of RAS, RAF, NF1, and/or RASSF1A.

Authors:  Terje Ahlquist; Irene Bottillo; Stine A Danielsen; Gunn I Meling; Torleiv O Rognum; Guro E Lind; Bruno Dallapiccola; Ragnhild A Lothe
Journal:  Neoplasia       Date:  2008-07       Impact factor: 5.715

6.  Correlation of clinicopathological features with immunohistochemical expression of cell cycle regulatory proteins p16 and retinoblastoma: distinct association with keratinisation and differentiation in oral cavity squamous cell carcinoma.

Authors:  D M Muirhead; H T Hoffman; R A Robinson
Journal:  J Clin Pathol       Date:  2006-02-07       Impact factor: 3.411

7.  Identification of an epigenetic biomarker panel with high sensitivity and specificity for colorectal cancer and adenomas.

Authors:  Guro E Lind; Stine A Danielsen; Terje Ahlquist; Marianne A Merok; Kim Andresen; Rolf I Skotheim; Merete Hektoen; Torleiv O Rognum; Gunn I Meling; Geir Hoff; Michael Bretthauer; Espen Thiis-Evensen; Arild Nesbakken; Ragnhild A Lothe
Journal:  Mol Cancer       Date:  2011-07-21       Impact factor: 27.401

8.  Hypermethylated MAL gene - a silent marker of early colon tumorigenesis.

Authors:  Guro E Lind; Terje Ahlquist; Matthias Kolberg; Marianne Berg; Mette Eknaes; Miguel A Alonso; Anne Kallioniemi; Gunn I Meling; Rolf I Skotheim; Torleiv O Rognum; Espen Thiis-Evensen; Ragnhild A Lothe
Journal:  J Transl Med       Date:  2008-03-17       Impact factor: 5.531

9.  A tissue-based comparative effectiveness analysis of biomarkers for early detection of colorectal tumors.

Authors:  Deeqa Ahmed; Stine A Danielsen; Trude H Aagesen; Michael Bretthauer; Espen Thiis-Evensen; Geir Hoff; Torleiv O Rognum; Arild Nesbakken; Ragnhild A Lothe; Guro E Lind
Journal:  Clin Transl Gastroenterol       Date:  2012-12-06       Impact factor: 4.488

10.  Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers.

Authors:  Terje Ahlquist; Guro E Lind; Vera L Costa; Gunn I Meling; Morten Vatn; Geir S Hoff; Torleiv O Rognum; Rolf I Skotheim; Espen Thiis-Evensen; Ragnhild A Lothe
Journal:  Mol Cancer       Date:  2008-12-31       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.